RLYB Insider Trading

Insider Ownership Percentage: 7.80%
Insider Buying (Last 12 Months): $24,120.00
Insider Selling (Last 12 Months): $5,915,500.00

Rallybio Insider Trading History Chart

This chart shows the insider buying and selling history at Rallybio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rallybio Share Price & Price History

Current Price: $6.45
Price Change: Price Decrease of -0.33 (-4.87%)
As of 02/3/2023 10:04 PM ET

This chart shows the closing price history over time for RLYB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Rallybio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2022Kush ParmarDirectorSell150,000$12.50$1,875,000.001,251,755View SEC Filing Icon  
5/23/2022Kush ParmarDirectorSell100,000$13.00$1,300,000.001,302,084View SEC Filing Icon  
3/21/2022Jeffrey M. FryerInsiderBuy3,000$8.04$24,120.00View SEC Filing Icon  
2/8/2022Opportunities I L.P. 5AmMajor ShareholderSell210,000$13.05$2,740,500.00View SEC Filing Icon  
1/19/2022Jeffrey M. FryerInsiderBuy1,400$8.70$12,180.00View SEC Filing Icon  
1/12/2022Stephen UdenInsiderBuy5,000$10.55$52,750.00View SEC Filing Icon  
1/10/2022Martin MackayCEOBuy5,504$10.10$55,590.40View SEC Filing Icon  
1/7/2022Jeffrey M. FryerInsiderBuy10,000$9.41$94,100.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Rallybio (NASDAQ:RLYB)

91.97% of Rallybio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RLYB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rallybio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/1/2023Canaan Partners XI LLC2,059,712$13.53M10.6%-14.5%6.431%Search for SEC Filing on Google Icon
11/15/2022State Street Corp252,592$3.66M0.0%+1.5%0.788%Search for SEC Filing on Google Icon
11/15/2022Northeast Financial Consultants Inc13,066$0.19M0.0%N/A0.041%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.798,636$11.56M0.0%+14.7%2.493%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.985,375$14.26M0.0%+6.0%3.076%Search for SEC Filing on Google Icon
11/14/2022Nuveen Asset Management LLC22,404$0.32M0.0%-14.2%0.070%Search for SEC Filing on Google Icon
11/14/2022MetLife Investment Management LLC10,279$0.15M0.0%N/A0.032%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP23,166$0.34M0.0%N/A0.072%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund10,337$0.15M0.0%-19.8%0.032%Search for SEC Filing on Google Icon
11/1/2022Tekla Capital Management LLC1,740,931$25.19M1.0%-9.8%5.418%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.37,838$0.29M0.0%+147.5%0.118%Search for SEC Filing on Google Icon
8/15/2022State Street Corp248,950$1.88M0.0%+57.0%0.775%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP402,000$3.04M0.0%+0.5%1.251%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC18,195$0.14M0.0%-27.5%0.057%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.7,466$56K0.0%-16.9%0.023%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp116,234$0.88M0.0%-11.6%0.362%Search for SEC Filing on Google Icon
8/12/2022FMR LLC2,893,557$21.85M0.0%0.0%9.006%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers19,190$0.15M0.0%+47.7%0.060%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.19,060$0.14M0.0%N/A0.059%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.10,009$75K0.0%-19.1%0.031%Search for SEC Filing on Google Icon
7/29/2022Tekla Capital Management LLC1,931,120$14.58M0.6%-12.0%6.010%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC59,543$0.42M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC59,543$0.42M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System7,694$54K0.0%+124.8%0.024%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.15,289$0.11M0.0%+17.0%0.048%Search for SEC Filing on Google Icon
5/16/2022State Street Corp158,573$1.11M0.0%+114.8%0.494%Search for SEC Filing on Google Icon
5/16/2022Novo Holdings A S435,944$3.04M0.1%N/A1.357%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC52,715$0.37M0.0%N/A0.164%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp131,432$0.92M0.0%+113.5%0.409%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.45,581$0.32M0.0%+183.5%0.142%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.8,984$63K0.0%+134.9%0.028%Search for SEC Filing on Google Icon
5/13/2022Tekla Capital Management LLC2,195,010$15.32M0.5%-4.9%6.832%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.710,049$4.96M0.0%+122.0%2.210%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.908,164$6.34M0.0%+88.6%2.826%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers12,995$91K0.0%N/A0.040%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp41,688$0.29M0.0%+145.6%0.130%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.12,374$86K0.0%-96.2%0.039%Search for SEC Filing on Google Icon
5/10/2022Sectoral Asset Management Inc.385,069$2.69M0.5%+27.8%1.198%Search for SEC Filing on Google Icon
2/9/2022AJU IB Investment Co. Ltd.754,678$7.20M10.0%N/A2.349%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp61,571$0.59M0.0%+7.1%0.192%Search for SEC Filing on Google Icon
2/3/2022Canaan Partners XI LLC2,409,712$22.99M5.9%N/A7.500%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC2,914$27K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP400,000$7.03M0.0%N/A1.245%Search for SEC Filing on Google Icon
11/15/2021Viking Global Investors LP4,194,777$73.74M0.2%N/A13.056%Search for SEC Filing on Google Icon
11/15/2021Sectoral Asset Management Inc527,136$9.27M0.8%N/A1.641%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP10,000$0.18M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/12/2021New Leaf Venture Partners L.L.C.2,301,603$40.46M11.7%N/A7.163%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC69,963$1.23M0.0%N/A0.218%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.292,204$5.14M0.0%N/A0.909%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG4,139$73K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund4,396$77K0.0%N/A0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rallybio logo
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.
Read More on Rallybio

Today's Range

Now: $6.45
Low: $6.28
High: $6.85

50 Day Range

MA: $6.16
Low: $4.67
High: $8.00

52 Week Range

Now: $6.45
Low: $4.54
High: $15.89

Volume

81,400 shs

Average Volume

55,939 shs

Market Capitalization

$206.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rallybio?

Rallybio's top insider investors include:
  1. Kush Parmar (Director)
  2. Jeffrey M Fryer (Insider)
  3. Martin Mackay (CEO)
  4. Opportunities I LP 5Am (Major Shareholder)
  5. Stephen Uden (Insider)
Learn More about top insider investors at Rallybio.

Who are the major institutional investors of Rallybio?

Rallybio's top institutional investors include:
  1. Canaan Partners XI LLC — 6.43%
Learn More about top institutional investors of Rallybio stock.

Which institutional investors are selling Rallybio stock?

In the last quarter, RLYB stock was sold by these institutional investors:
  1. Canaan Partners XI LLC
Within the previous year, company insiders that have sold Rallybio company stock include:
  1. Kush Parmar (Director)
  2. Jeffrey M Fryer (Insider)
Learn More investors selling Rallybio stock.